Medivo is an online health startup that has raised $15 million in funding. Medivo has plans on using the funding to expand their health monitoring platform. Doctors will be able to connect with clinical labs. Medivo’s goal is to improve lives by providing easier access to quality healthcare. This round of funding was led by the Merck Global Health Innovation Fund (GHIF) with participation from existing investors Safeguard Scientifics and MentorTech Ventures.
The company’s applications will help improve communications between patients and providers. The patients will get free access to tools that can track symptoms. The systems can also help patients understand the connections between symptoms and factors like medications and diets. Medivo organizes labs results for providers so that they can identify which patients require office visits and prioritizes them.
Medivo’s platform has modules for physicians and patients that have various conditions such as gout, hepatitis C, low testosterone, myelogenous leukemia, etc. The funding will be used for supporting conditions like rheumatoid arthritis, hepatitis B, HIV, colon cancer, breast cancer, prostate cancer, myelofibrosis, multiple myeloma, growth hormone deficiency, osteoporosis, hypothyroidism, and multiple sclerosis.
Medivo co-founder and CEO Sundeep Bhan previously founded Medsite, which was acquired by WebMD in 2006. The other co-founder is Dr. Destry Sulkes, whom has worked in the healthcare IT business for more than 15 years.